Therapeutics

Isarna Therapeutics has announced positive data from its international multicenter study evaluating ISTH0036, a selective TGF-β2-blocking antisense oligonucleotide, in patients with wet age-related macular degeneration (nAMD) and diabetic macular...

Atossa Therapeutics, Inc. (NASDAQ: ATOS), a clinical-stage biopharmaceutical company, announced the issuance of a new patent for its breast cancer treatment formulations, specifically U.S. Patent No. 12,281,056. This patent...

Marea Therapeutics, Inc., a clinical-stage biotechnology company, has announced its upcoming participation in the 93rd European Atherosclerosis Society (EAS) Congress, set to take place from May 4-7, 2025, in...

BioXcel Therapeutics, Inc. a pharmaceutical company with a market capitalization of $17.2 million, has expanded its Board of Directors by appointing Dr. Rajiv Patni as a new Class II...